Taiwan Semiconductor Manufacturing Co (TSMC), the world's leading chipmaker, recently updated its 2024 revenue growth forecasts following better-than-expected quarterly results. Given the potential fundamentals arising from this revision, investors have a chance to take advantage of the opportunity to bolster their investment portfolio with a strong player in the technology space.

On Tuesday, during the US trading session, the price of gold managed to break the all-time high. This was in the wake of the bullish trend that has accompanied gold since the beginning of this year.* This sharp rise is largely attributed to growing expectations that the Federal Reserve will move to cut interest rates at its upcoming September meeting. The question for investors is clear: "Buy or wait?"

The AI revolution is giving a major boost to Taiwan's economy, boosting record export levels and presenting a lucrative opportunity for investors. With companies on the island shipping more than US$42 billion worth of graphics processing units (GPUs) and related equipment last year, Taiwan has become a crucial player on the global technology stage. This sharp increase from almost negligible numbers in previous years underlines Taiwan's key role in the AI and semiconductor sectors.

Nokia's ambitious move to acquire US optical network equipment manufacturer Infinera represents a significant strategic step for the company. The acquisition enables the Finnish telecoms giant to take advantage of the growing investment in data centres driven by the rise of artificial intelligence and propel it to a high ranking ahead of its competitors.

Paramount Global is actively exploring partnerships for its international TV streaming business, which could significantly increase the scale and profitability of its online service. This strategic direction was announced by co-CEO Chris McCarthy during a Tuesday meeting with employees. McCarthy emphasized that such a partnership could change the economics of Paramount's streaming operations and potentially create a model for similar initiatives in the U.S. market.

Amazon (NASDAQ: AMZN) is actively continuing to redefine the retail landscape. This time, it has made significant progress in the pharmaceutical sector. In a recent announcement, Amazon's pharmaceutical unit revealed the expansion of its RxPass prepaid service to include people who are enrolled in government-backed Medicare insurance plans. This strategic move allows the company to gain a larger share of the pharmacy market and compete directly with established players such as CVS and Walgreens. For investors, this expansion represents an interesting opportunity to use Amazon's innovative approach to their advantage.